Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 100 shares at $902.66 ($90K) on 2024-05-01, disclosed to the SEC on 2024-05-03.
Scheduled sale ($90k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $889.50 | 3 | $3K | 3.0% |
| 2 | $890.75 | 2 | $2K | 2.0% |
| 3 | $891.52 | 7 | $6K | 6.9% |
| 4 | $892.50 | 9 | $8K | 8.9% |
| 5 | $893.16 | 5 | $4K | 5.0% |
| 6 | $895.38 | 2 |
| $2K |
| 2.0% |
| 7 | $896.59 | 3 | $3K | 3.0% |
| 8 | $897.68 | 9 | $8K | 9.0% |
| 9 | $898.51 | 17 | $15K | 17.0% |
| 10 | $899.37 | 7 | $6K | 7.0% |
| 11 | $900.45 | 5 | $5K | 5.0% |
| 12 | $901.41 | 4 | $4K | 4.0% |
| 13 | $902.66 | 1 | $903 | 1.0% |
| 14 | $903.35 | 1 | $903 | 1.0% |
| 15 | $904.80 | 1 | $905 | 1.0% |
| 16 | $905.50 | 2 | $2K | 2.0% |
| 17 | $906.26 | 4 | $4K | 4.0% |
| 18 | $907.54 | 2 | $2K | 2.0% |
| 19 | $909.49 | 4 | $4K | 4.0% |
| 20 | $910.47 | 6 | $5K | 6.1% |
| 21 | $911.39 | 4 | $4K | 4.1% |
| 22 | $912.29 | 1 | $912 | 1.0% |
| 23 | $913.21 | 1 | $913 | 1.0% |
| Total | $899.61 avg | 100 | $90K | 100% |
| Filing → |
| REGN | SELL | 2026-04-03 | $78K | — | Filing → |
| REGN | SELL | 2026-03-03 | $79K | — | Filing → |
| REGN | SELL | 2026-02-11 | $78K | — | Filing → |